Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328 (6 March), doi:10.1136/bmj.328.7439.0
Sulfadoxine-pyrimethamine has good therapeutic efficacy but diminishing clinical and parasitological efficacy ten years after its introduction in Malawi. Plowe and colleagues (p 545) studied 1377 patients treated with sulfadoxine-pyrimethamine from 1998 to 2002 in Malawi. Although the clinical response in the first 14 days was adequate and did not change over the five years, the rates of parasite clearance declined over time. This may presage a decline in efficacy and new effective treatment may soon be required, the authors say.
|
|
Credit: CAROLINE PENN/PANOS
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?